{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:13:13Z","timestamp":1778253193799,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ymthe.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T20:38:56Z","timestamp":1592253536000},"page":"2161-2176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["miR-143 Regulates Lysosomal Enzyme Transport across the Blood-Brain Barrier and Transforms CNS Treatment for Mucopolysaccharidosis Type I"],"prefix":"10.1016","volume":"28","author":[{"given":"Yi","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.06.011_bib1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.06.011_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2008.84","article-title":"Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse","volume":"16","author":"Urayama","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnins.2015.00021","article-title":"Efflux transporters in blood-brain interfaces of the developing brain","volume":"9","author":"Strazielle","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2020.06.011_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2020.06.011_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2020.06.011_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2352-4642(17)30087-1","article-title":"Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS","volume":"2","author":"Giugliani","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.ymthe.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic stem cell gene therapy for storage disease: current and new indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.06.011_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2014the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2017.05.005","article-title":"Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: a review of the literature","volume":"121","author":"Janzen","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.06.011_bib13","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138920111795542679","article-title":"Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses","volume":"12","author":"Pan","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib15","article-title":"The mucopolysaccharidoses","volume":"chapter 136","author":"Neufeld","year":"2007"},{"key":"10.1016\/j.ymthe.2020.06.011_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/emmm.201302668","article-title":"The final frontier\u2014crossing the blood-brain barrier","volume":"5","author":"Sly","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0405042101","article-title":"Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier","volume":"101","author":"Urayama","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2020.06.011_bib19","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1096\/fj.201600435RR","article-title":"Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation","volume":"30","author":"Lopez-Ramirez","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2020.06.011_bib20","doi-asserted-by":"crossref","first-page":"12812","DOI":"10.1073\/pnas.1507094112","article-title":"Endothelial miR-17\u223c92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling","volume":"112","author":"Landskroner-Eiger","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib21","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1508426112","article-title":"Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization","volume":"112","author":"Liu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"e0197379","DOI":"10.1371\/journal.pone.0197379","article-title":"Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: reference and marker genes with cellular composition","volume":"13","author":"Dai","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2020.06.011_bib24","doi-asserted-by":"crossref","first-page":"D149","DOI":"10.1093\/nar\/gkm995","article-title":"The microRNA.org resource: targets and expression","volume":"36","author":"Betel","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.06.011_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ymthe.2020.06.011_bib26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","article-title":"MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.06.011_bib28","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1093\/nar\/gku461","article-title":"Lessons from miR-143\/145: the importance of cell-type localization of miRNAs","volume":"42","author":"Kent","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"R2","key":"10.1016\/j.ymthe.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddq367","article-title":"Analysis of microRNA knockouts in mice","volume":"19","author":"Park","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainresrev.2003.11.002","article-title":"The insulin-like growth factor-II\/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system","volume":"44","author":"Hawkes","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ymthe.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41423-018-0031-1","article-title":"Mannose-6-phosphate receptor: a novel regulator of T\u00a0cell immunity","volume":"15","author":"Ara","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","article-title":"Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation","volume":"37","author":"Schwartz","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.06.011_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12033-012-9519-6","article-title":"Secreted luciferase for in\u00a0vivo evaluation of systemic protein delivery in mice","volume":"53","author":"El-Amouri","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib35","doi-asserted-by":"crossref","first-page":"19958","DOI":"10.1073\/pnas.0908528106","article-title":"Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib36","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1073\/pnas.1323155111","article-title":"Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome","volume":"111","author":"Dai","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.06.011_bib38","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/mt.2014.152","article-title":"Normalization and improvement of CNS deficits in mice with Hurler syndrome after long-term peripheral delivery of BBB-targeted iduronidase","volume":"22","author":"El-Amouri","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.06.011_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1096-7192(03)00116-1","article-title":"Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow","volume":"79","author":"Zheng","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.06.011_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"Pan","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2020.06.011_bib41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.conb.2013.06.006","article-title":"\u201cSealing off the CNS\u201d: cellular and molecular regulation of blood-brain barriergenesis","volume":"23","author":"Siegenthaler","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib42","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.06.011_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0271678X15614589","article-title":"Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier","volume":"36","author":"Urayama","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymthe.2020.06.011_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.4814","article-title":"Fine-tuning vascular fate during endothelial-mesenchymal transition","volume":"241","author":"Xiao","year":"2017","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib46","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster","volume":"119","author":"Boettger","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.06.011_bib47","doi-asserted-by":"crossref","first-page":"52361","DOI":"10.1074\/jbc.C400438200","article-title":"MicroRNA-143 regulates adipocyte differentiation","volume":"279","author":"Esau","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.06.011_bib48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib49","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M112.373084","article-title":"MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene","volume":"287","author":"Fang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.06.011_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ncb2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2020.06.011_bib51","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.116.305178","article-title":"TGF\u03b2 triggers miR-143\/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization","volume":"116","author":"Climent","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2020.06.011_bib52","doi-asserted-by":"crossref","first-page":"35642","DOI":"10.1038\/srep35642","article-title":"Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse","volume":"6","author":"Bai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.06.011_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2011.11.005","article-title":"\u03b22 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease","volume":"105","author":"Koeberl","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.06.011_bib54","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1073\/pnas.192353499","article-title":"Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs","volume":"99","author":"Ponder","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.06.011_bib55","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"Cressant","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.06.011_bib56","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.06.011_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2020.06.011_bib58","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.molpharmaceut.7b00200","article-title":"Blood-brain barrier penetrating biologic TNF-\u03b1 Inhibitor for Alzheimer\u2019s disease","volume":"14","author":"Chang","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2020.06.011_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40259-017-0248-z","article-title":"Delivery of biologics across the blood-brain barrier with molecular Trojan horse technology","volume":"31","author":"Pardridge","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.ymthe.2020.06.011_bib60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2020.06.011_bib61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trecan.2017.12.008","article-title":"MicroRNA-based drugs for brain tumors","volume":"4","author":"Anthiya","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2020.06.011_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.06.011_bib63","doi-asserted-by":"crossref","first-page":"e69230","DOI":"10.1371\/journal.pone.0069230","article-title":"Characterization of microRNA expression profiles and the discovery of novel microRNAs involved in cancer during human embryonic development","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.06.011_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","article-title":"Endogenous human microRNAs that suppress breast cancer metastasis","volume":"451","author":"Tavazoie","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.06.011_bib65","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2020.06.011_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jgm.1141","article-title":"Co-expression of MGMTP140K and \u03b1-l-iduronidase in primary hepatocytes from mucopolysaccharidosis type I mice enables efficient selection with metabolic correction","volume":"10","author":"Wang","year":"2008","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2020.06.011_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/glycob\/cwg082","article-title":"Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies","volume":"13","author":"Barbosa","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2020.06.011_bib68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4081\/916","article-title":"Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system","volume":"48","author":"Mazzetti","year":"2004","journal-title":"Eur. J. Histochem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620303014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620303014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:58:21Z","timestamp":1761501501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620303014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1525001620303014"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.06.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-143 Regulates Lysosomal Enzyme Transport across the Blood-Brain Barrier and Transforms CNS Treatment for Mucopolysaccharidosis Type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}